Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
|
disease |
|
Neoplastic Process
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Catatonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Non-Hereditary Clear Cell Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
15
|
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Cholangiolocellular Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
16
|
1
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Influenza A (H3N2)
|
disease |
|
Disease or Syndrome
|
18
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Clear cell papillary renal cell carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Infectious colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adiponectin Measurement
|
phenotype |
|
Laboratory Procedure
|
25
|
70
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Oncocytoma, renal
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
34
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Perihilar Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
41
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasm of uncertain or unknown behavior of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
|
0 |
|
|
|
Blastic plasmacytoid dendritic cell neoplasm
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
46
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nonnuclear polymorphic congenital cataract
|
disease |
|
Congenital Abnormality
|
71
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Thymic Carcinoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
82
|
8
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Body Fat Distribution
|
phenotype |
|
Finding
|
90
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Influenza A virus infection
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
117
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Extrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
119
|
3
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
MAJOR AFFECTIVE DISORDER 8
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
126
|
8
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
MAJOR AFFECTIVE DISORDER 9
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
126
|
8
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
MAJOR AFFECTIVE DISORDER 7
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
127
|
8
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Sarcomatoid Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
134
|
|
0.300 |
None |
1.000 |
2 |
|
2011 |
2013 |
Metastatic Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
144
|
9
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Metastatic Renal Cell Cancer
|
disease |
|
Neoplastic Process
|
145
|
9
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
MAJOR AFFECTIVE DISORDER 4
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
160
|
34
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
MAJOR AFFECTIVE DISORDER 6
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
160
|
34
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |